International Society of Andrology
ISA - Global Leader in Male Reproductive Health
Announcement
The Fifth International Congress on Male Contraceptive methods will be held on June 5, 2026, in Bethesda, MD, USA. This joint event is organized by the International Consortium for Male Contraception (ICMC), the Population Council, the Male Contraception Initiative (MCI), and the National Institute of Child Health and Development (NICHD).
This meeting will highlight the progress achieved over a decade of research and advocacy aimed at advancing men’s health. Internationally recognized experts will present the latest scientific developments and research findings in the field of male contraception.
The target audience includes reproductive endocrinologists, andrologists, urologists, and family planning providers s, primary care physicians, men’s health physicians, contraceptive drug developers, fellows, and scientists interested in contraception. We expect the meeting to stimulate further interest in male contraceptive methods and to engage industrial partners in investing in continued research and development, with the goal of expanding contraceptive options for men and contributing to improved andrology health globally.
Learn more about the program and register here: https://icmc2026.eventbrite.com
The meeting is held under the auspices of the European Society of Contraception and Reproductive Health (ESC), the European Academy of Andrology, The International Society of Andrology, the European Society of Endocrinology (ESE), the Francophone Society of Contraception (SFC), the Male Contraception Initiative, and the Population Council.
The 2026 Congress will be held with the generous support from the Population Council, the Male Contraceptive Initiative, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, Contraline, NextLife Sciences, Sacyl Pharmaceuticals Inc, YourChoice Therapeutics.
We look forward to seeing you in Bethesda on June 5, 2026!
Regine Sitruk-Ware, MD, Christina Wang, MD, PhD David Serfaty, MD,
Population Council, CEO of ICMC Professor, CFO of ICMC President of ICMC
And the Organizing Scientific Committee:
Richard Anderson (UK), Diana Blithe (USA), Philippe Bouchard (FR), Kristina Gemzell-Danielsson (SE), Stephanie Page (USA), David Serfaty (FR), Regine Sitruk-Ware (USA) (Chair), Heather Vahdat (USA), Christina Wang (USA)
Announcement
The Fifth International Congress on Male Contraceptive methods will be held on June 5, 2026, in Bethesda, MD, USA. This joint event is organized by the International Consortium for Male Contraception (ICMC), the Population Council, the Male Contraception Initiative (MCI), and the National Institute of Child Health and Development (NICHD).
This meeting will highlight the progress achieved over a decade of research and advocacy aimed at advancing men’s health. Internationally recognized experts will present the latest scientific developments and research findings in the field of male contraception.
The target audience includes reproductive endocrinologists, andrologists, urologists, and family planning providers s, primary care physicians, men’s health physicians, contraceptive drug developers, fellows, and scientists interested in contraception. We expect the meeting to stimulate further interest in male contraceptive methods and to engage industrial partners in investing in continued research and development, with the goal of expanding contraceptive options for men and contributing to improved andrology health globally.
Learn more about the program and register here: https://icmc2026.eventbrite.com
The meeting is held under the auspices of the European Society of Contraception and Reproductive Health (ESC), the European Academy of Andrology, The International Society of Andrology, the European Society of Endocrinology (ESE), the Francophone Society of Contraception (SFC), the Male Contraception Initiative, and the Population Council.
The 2026 Congress will be held with the generous support from the Population Council, the Male Contraceptive Initiative, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, Contraline, NextLife Sciences, Sacyl Pharmaceuticals Inc, YourChoice Therapeutics.
We look forward to seeing you in Bethesda on June 5, 2026!
Regine Sitruk-Ware, MD, Christina Wang, MD, PhD David Serfaty, MD,
Population Council, CEO of ICMC Professor, CFO of ICMC President of ICMC
And the Organizing Scientific Committee:
Richard Anderson (UK), Diana Blithe (USA), Philippe Bouchard (FR), Kristina Gemzell-Danielsson (SE), Stephanie Page (USA), David Serfaty (FR), Regine Sitruk-Ware (USA) (Chair), Heather Vahdat (USA), Christina Wang (USA)